MARKET

PFE

PFE

Pfizer
NYSE

Real-time Quotes | Nasdaq Last Sale

42.79
-0.27
-0.63%
After Hours: 42.74 -0.05 -0.12% 19:59 07/29 EDT
OPEN
43.23
PREV CLOSE
43.06
HIGH
43.30
LOW
42.62
VOLUME
29.02M
TURNOVER
--
52 WEEK HIGH
43.74
52 WEEK LOW
32.80
MARKET CAP
239.53B
P/E (TTM)
25.69
1D
5D
1M
3M
1Y
5Y
S.Korea announces vaccination plan for 18-49 year olds
reuters.com · 33m ago
First batch of U.S. donated Pfizer vaccines arrives in Thailand
reuters.com · 2h ago
Japan OKs administration of AstraZeneca shots after delay - media
reuters.com · 3h ago
Brands Who Focus On More Than Just Their Bottom Lines
Corporate Social Responsibility is a term that has been faked by many but genuine CSR remains a noble effort that businesses, both large and small, make to create a positive impact on the planet and the community. These rare companies choose to do what is ...
Benzinga · 9h ago
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
Investor Place · 9h ago
Saudi Arabia to open for tourist visa holders starting AUG 1 -Tourism Ministry
reuters.com · 10h ago
Biden expects decision by early fall on non-emergency use authorization for COVID vaccines
reuters.com · 10h ago
Israel to offer Pfizer vaccine booster shots to those over 60
Publicly funded health maintenance organization says third doses of the vaccine will begin being administered on Sunday.
MarketWatch · 10h ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PFE. Analyze the recent business situations of Pfizer through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 24 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PFE stock price target is 43.54 with a high estimate of 53.00 and a low estimate of 38.00.
EPS
Institutional Holdings
Institutions: 2.88K
Institutional Holdings: 3.71B
% Owned: 66.23%
Shares Outstanding: 5.60B
TypeInstitutionsShares
Increased
1.19K
122.24M
New
144
19.30M
Decreased
1.06K
159.57M
Sold Out
131
13.34M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.26%
Pharmaceuticals & Medical Research
-0.31%
Key Executives
Chairman/Chief Executive Officer/Director
Albert Bourla
President
John Young
Chief Financial Officer/Executive Vice President
Frank D'amelio
Corporate Executive
Angela Hwang
Executive Vice President/Chief Technology Officer
Lidia Fonseca
Executive Vice President/Chief Compliance Officer/Chief Risk Officer
Rady Johnson
Executive Vice President/General Counsel
Douglas Lankler
Executive Vice President
Sally Susman
Senior Vice President
Christopher Stevo
Chief Scientific Officer
Mikael Dolsten
Lead Director/Independent Director
Shantanu Narayen
Independent Director
Ronald Blaylock
Independent Director
Susan Desmond-Hellmann
Independent Director
Joseph Echevarria
Independent Director
Scott Gottlieb
Independent Director
Helen Hobbs
Independent Director
Susan Hockfield
Independent Director
Dan Littman
Independent Director
Suzanne Nora Johnson
Independent Director
James Quincey
Independent Director
James Smith
Declaration Date
Dividend Per Share
Ex-Div Date
06/24/2021
Dividend USD 0.39
07/29/2021
04/22/2021
Dividend USD 0.39
05/06/2021
12/11/2020
Dividend USD 0.39
01/28/2021
09/24/2020
Dividend USD 0.38
11/05/2020
06/25/2020
Dividend USD 0.38
07/30/2020
04/23/2020
Dividend USD 0.38
05/07/2020
12/16/2019
Dividend USD 0.38
01/30/2020
09/24/2019
Dividend USD 0.36
11/07/2019
06/27/2019
Dividend USD 0.36
08/01/2019
04/25/2019
Dividend USD 0.36
05/09/2019
12/14/2018
Dividend USD 0.36
01/31/2019
09/27/2018
Dividend USD 0.34
11/08/2018
06/28/2018
Dividend USD 0.34
08/02/2018
04/26/2018
Dividend USD 0.34
05/10/2018
12/18/2017
Dividend USD 0.34
02/01/2018
09/27/2017
Dividend USD 0.32
11/09/2017
06/23/2017
Dividend USD 0.32
08/02/2017
04/28/2017
Dividend USD 0.32
05/10/2017
12/13/2016
Dividend USD 0.32
02/01/2017
09/23/2016
Dividend USD 0.3
11/08/2016
About PFE
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Webull offers kinds of Pfizer Inc. stock information, including NYSE:PFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PFE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PFE stock methods without spending real money on the virtual paper trading platform.